Literature DB >> 21358282

Measuring cooperative Rev protein-protein interactions on Rev responsive RNA by fluorescence resonance energy transfer.

Thomas Vercruysse1, Sonalika Pawar, Wim De Borggraeve, Els Pardon, George N Pavlakis, Christophe Pannecouque, Jan Steyaert, Jan Balzarini, Dirk Daelemans.   

Abstract

The export of viral RNA from the nucleus to the cytoplasm of the cellular host is a crucial step in the life cycle of HIV-1 that is mediated by the viral Rev protein. One aspect of the Rev function, its multimerization, is still unexplored as a target for antiviral therapy. This is partly due to the lack of a fast and solid system to measure Rev multimerization. We have developed a high throughput in vitro Rev multimerization assay based on fluorescence resonance energy transfer (FRET) in which real-time Rev-Rev interactions can be measured both in the absence and the presence of Rev specific RRE RNA. Well-characterized Rev multimerization deficient mutants showed reduced FRET as well as unlabeled Rev molecules were able to inhibit the FRET signal demonstrating the specificity of the assay. Upon multimerization along RRE RNA the FRET signal significantly increased but dropped again at equimolar Rev/RRE ratios suggesting that in this condition most Rev molecules are bound as monomers to the RRE. Furthermore, using this assay, we demonstrate that a previously selected llama heavy-chain only antibody was shown to not only prevent the development of Rev multimers but also disassemble the already formed complexes confirming the dynamic nature of the Rev-Rev interactions. The in vitro FRET based multimerization assay facilitates the further study of the basic mechanism of cooperative Rev multimerization along the RRE and is also widely applicable to study the assembly of other functional complexes involving protein homo-multimerization or cooperative protein-protein interactions on RNA or DNA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21358282      PMCID: PMC3127102          DOI: 10.4161/rna.8.2.13782

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  66 in total

Review 1.  Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains.

Authors:  S Muyldermans; C Cambillau; L Wyns
Journal:  Trends Biochem Sci       Date:  2001-04       Impact factor: 13.807

2.  Regulation by HIV Rev depends upon recognition of splice sites.

Authors:  D D Chang; P A Sharp
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

3.  Structural and functional characterization of the human immunodeficiency virus rev protein.

Authors:  A Perkins; A W Cochrane; S M Ruben; C A Rosen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

4.  HIV-1 Rev expressed in recombinant Escherichia coli: purification, polymerization, and conformational properties.

Authors:  P T Wingfield; S J Stahl; M A Payton; S Venkatesan; M Misra; A C Steven
Journal:  Biochemistry       Date:  1991-07-30       Impact factor: 3.162

5.  Sequence requirements for Rev multimerization in vivo.

Authors:  S J Madore; L S Tiley; M H Malim; B R Cullen
Journal:  Virology       Date:  1994-07       Impact factor: 3.616

6.  Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA.

Authors:  B Wolff; J J Sanglier; Y Wang
Journal:  Chem Biol       Date:  1997-02

7.  Chimeric RNase H-competent oligonucleotides directed to the HIV-1 Rev response element.

Authors:  Chrissy E Prater; Anthony D Saleh; Maggie P Wear; Paul S Miller
Journal:  Bioorg Med Chem       Date:  2007-06-02       Impact factor: 3.641

8.  Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: structure-activity relationship and mechanism of action.

Authors:  Tine Van Neck; Christophe Pannecouque; Els Vanstreels; Miguel Stevens; Wim Dehaen; Dirk Daelemans
Journal:  Bioorg Med Chem       Date:  2008-09-20       Impact factor: 3.641

9.  Functional analysis of CAR, the target sequence for the Rev protein of HIV-1.

Authors:  E T Dayton; D M Powell; A I Dayton
Journal:  Science       Date:  1989-12-22       Impact factor: 47.728

10.  Protein structure and oligomerization are important for the formation of export-competent HIV-1 Rev-RRE complexes.

Authors:  Stephen P Edgcomb; Angelique Aschrafi; Elizabeth Kompfner; James R Williamson; Larry Gerace; Mirko Hennig
Journal:  Protein Sci       Date:  2008-01-24       Impact factor: 6.725

View more
  7 in total

1.  A general protocol for the generation of Nanobodies for structural biology.

Authors:  Els Pardon; Toon Laeremans; Sarah Triest; Søren G F Rasmussen; Alexandre Wohlkönig; Armin Ruf; Serge Muyldermans; Wim G J Hol; Brian K Kobilka; Jan Steyaert
Journal:  Nat Protoc       Date:  2014-02-27       Impact factor: 13.491

Review 2.  Nanobodies to Study G Protein-Coupled Receptor Structure and Function.

Authors:  Aashish Manglik; Brian K Kobilka; Jan Steyaert
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016-12-07       Impact factor: 13.820

3.  Detection of viral RNA by fluorescence in situ hybridization (FISH).

Authors:  Kishanda Vyboh; Lara Ajamian; Andrew J Mouland
Journal:  J Vis Exp       Date:  2012-05-05       Impact factor: 1.355

Review 4.  Phages and HIV-1: from display to interplay.

Authors:  Sylvie Delhalle; Jean-Claude Schmit; Andy Chevigné
Journal:  Int J Mol Sci       Date:  2012-04-13       Impact factor: 6.208

5.  The HIV-1 Rev response element (RRE) adopts alternative conformations that promote different rates of virus replication.

Authors:  Chringma Sherpa; Jason W Rausch; Stuart F J Le Grice; Marie-Louise Hammarskjold; David Rekosh
Journal:  Nucleic Acids Res       Date:  2015-04-08       Impact factor: 16.971

6.  A time-of-drug addition approach to target identification of antiviral compounds.

Authors:  Dirk Daelemans; Rudi Pauwels; Erik De Clercq; Christophe Pannecouque
Journal:  Nat Protoc       Date:  2011-06-02       Impact factor: 13.491

7.  Mapping the binding interface between an HIV-1 inhibiting intrabody and the viral protein Rev.

Authors:  Thomas Vercruysse; Eline Boons; Tom Venken; Els Vanstreels; Arnout Voet; Jan Steyaert; Marc De Maeyer; Dirk Daelemans
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.